Thromb Haemost 1979; 42(05): 1615-1619
DOI: 10.1055/s-0038-1657065
Original Article
Schattauer GmbH Stuttgart

Human Platelet Acetylcholinesterase: The Effects of Anticholinesterases on Platelet Function

Martin J Smith
The Gundersen Clinic, Ltd. and La Crosse Lutheran Hospital, La Crosse, Wisconsin, U.S.A.
,
Boyd Braem
The Gundersen Clinic, Ltd. and La Crosse Lutheran Hospital, La Crosse, Wisconsin, U.S.A.
,
Kent D Davis
The Gundersen Clinic, Ltd. and La Crosse Lutheran Hospital, La Crosse, Wisconsin, U.S.A.
› Author Affiliations
Further Information

Publication History

Received 02 May 1979

Accepted 11 December 1979

Publication Date:
18 February 2019 (online)

Summary

Platelet acetylcholinesterase (AChE) activity was measured in gel-filtered platelet preparations. Three different anticholinesteratic agents (eserine, neostigmine, and diiso- propylphosphorofluoridate) at final concentrations of 10 μM caused complete inhibition of AChE activity after 30 min incubation at room temperature with either platelet-rich plasma or gel-filtered platelets. Complete inhibition of platelet AChE had no effect on platelet aggregation, factor-3 availability, and plasma clot retraction. We conclude that platelet membrane AChE activity is not required for normal platelet function as measured by these in vitro parameters.

 
  • References

  • 1 Aoki N, Naito K, Yoshida N. 1978; Inhibition of platelet aggregation by protease inhibitors. Possible involvement of proteases in platelet aggregation Blood 52: 1
  • 2 Born GV R. 1962; Aggregation of blood platelets by adenosine and its reversal. Nature 194: 927
  • 3 Chuang HY K. 1973; Cholinesterase activities of intact platelets as measured by an improved radiometric method. Biochemica et Biophysica Acta 321: 546
  • 4 Chuang HY K, Mason RG. 1973; A preliminary study of the acetylcholinesterase and butyrylcholinesterase of human platelets. Thrombosis et Diathesis Haemorrhagica 30: 148
  • 5 Ellman GL, Courtney KD, Andre Jr V, Featherstone RM. 1961; A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology 7: 88
  • 6 Kilburn EP, Firkin BG. 1968; A study of human platelet proteases. Thrombosis et Diathesis Haemorrhagica 20: 366
  • 7 Koelle GB, ed Goodman LS, Gilman A. 1970. The Pharmacological Basis of Therapeutics. 4. MacMillan Company; New York: p 443
  • 8 Low MG, Finean JB. 1977; Non-lytic release of acetylcholinesterase from erythrocytes by a phosphatidylinositol-specific phospholipase C. Federation of European Biochemical Societies Letters 82: 143
  • 9 Mustard JF, Packham MA, Senyi A. 1967; The effect of DFP on platelet function in vitro and vivo. Journal of Laboratory and Clinical Medicine 70: 1003
  • 10 Saba SR, Mason RG. 1970; Acetylcholine, cholinesterase activity, and the aggregability of human platelets. Proceedings of the Society for Experimental Biology and Medicine 135: 104
  • 11 Silver A. 1974. The Biology of Cholinesterases. North-Holland Publishing Company; Amsterdam:
  • 12 Spaet TH, Cintron J. 1965; Studies on platelet factor-3 availability. British Journal of Haematology 11: 269
  • 13 Tangen O, Berman HJ, Marfey P. 1971; Gel filtration: A new technique for separation of blood platelets from plasma. Thrombosis et Diathesis Haemorrhagica 25: 268
  • 14 Vincent D, Maupin B, Marques-Vincent MC. 1962; Sur les estérase des plaquettes du sang humain (cholinesterase et arylestérase). Comptes Rendus de Societe de Biologie (Paris) 156: 34